REAL-WORLD HEALTH OUTCOMES, ECONOMIC IMPACTS, AND COST EFFECTIVENESS ASSOCIATED WITH INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN A MEDIUM-SIZED CITY OF CHINA

May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1157
https://www.valueinhealthjournal.com/article/S1098-3015(16)01225-0/fulltext
Section Title : Muscular-Skeletal Disorders - Cost Studies
Section Order : 834
First Page : A235
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01225-0&doi=10.1016/j.jval.2016.03.1157
HEOR Topics :
Tags :
Regions :